CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 106 enrolled
Drug / intervention
Functional Living Index - Emesisbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00696280
NCT00696280N/ACompleted
CompareCT.gov

Observational Study of Delayed Nausea and Vomiting Following Administration of Carboplatin Containing Regimens for Treatment of Cancer

Washington University School of Medicine·observational·Posted Jun 12, 2008·Updated Jun 12, 2013

In Brief

An observational study evaluating Functional Living Index - Emesis for Vomiting. Completed, enrolled 106 participants across 1 site.

Detailed Summary

Delayed emesis following administration of carboplatin-based chemotherapy despite prophylaxis with standard antiemetic prophylaxis (5-HT3 and corticosteroid) remains a clinically significant and distressing problem for patients with cancer. The incidence of delayed emesis appears to be higher in women compared to men.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsVomiting
CountriesUnited States
CollaboratorsMerck Sharp & Dohme LLC

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 12, 2008
Enrollment StartNov 1, 2006
Primary CompletionNov 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 18.1 years ago

Interventions

Functional Living Index - Emesisbehavioral